Biotech Stock Alert - NanoViricides (NYSE: NNVC)
For years, doctors have known that viral infections can cause inflammation, but recent studies have revealed a more alarming connection: viruses may reawaken "sleeping" cancer cells, leading to a resurgence of metastatic cancer. Now, a clinical-stage drug candidate, NV-387, is showing promise in fighting both viral infections and…
